한글목차

인수 공통 감염증 치료제 시장 규모는 최근, 현저한 성장을 보이고 있습니다. 2025년 425억 1,000만 달러에서 2026년에는 454억 8,000만 달러로, CAGR 7.0%로 확대할 전망입니다. 지난 수년간의 성장에는 인수공통전염병의 빈번한 전파 사례, 동물 집단내 질병 감시 체계의 한계, 기존 항생제에 대한 높은 의존도, 동물 위생과 인간 위생의 연계 전략 부족, 인간과 동물의 접촉 기회 증가 등이 원인으로 꼽히고 있습니다.

인수 공통 감염증 치료 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 577억 7,000만 달러에 달하며, CAGR은 6.2%에 달할 전망입니다. 예측 기간 중의 성장에는 인수공통전염병 진단 및 치료 기술의 발전, 원헬스 접근법의 보급 확대, 인수공통전염병 대책에 대한 정부 자금 증가, 동물의 백신 접종률 향상, 전 세계 질병 감시 프로그램의 확대 등이 요인으로 작용할 것으로 보입니다. 예측 기간의 주요 동향으로는 인수공통전염병 발생률 증가, 예방 치료 및 예방책에 대한 관심 증가, 광범위 항감염 치료제에 대한 수요 증가, 동물과 인간의 건강을 통합한 프로그램 확대, 조기 진단 및 신속한 치료 시작에 대한 중요성 등을 들 수 있습니다.

향후 수년간 동물성 단백질에 대한 수요 증가는 인수공통전염병 치료제 시장의 성장을 촉진할 것으로 예측됩니다. 인수공통전염병 치료는 전파 경로에 대한 이해 증진, 효과적인 치료법 개발, 공중보건 위험 감소를 위한 예방 전략 실행을 통해 동물성 단백질 섭취와 관련된 질병을 관리할 수 있도록 돕습니다. 예를 들어 2025년 3월 호주 통계청(ABS)이 발표한 자료에 따르면 호주의 1인당 육류 및 가금류 제품 소비량은 2023-24년 대비 2.3% 증가하여 국민 식단에서 동물성 단백질 섭취량이 중량 기준으로 눈에 띄게 증가하고 있는 것으로 나타났습니다. 증가했습니다. 따라서 동물성 단백질에 대한 수요 증가가 인수공통전염병 치료제 시장의 성장에 기여하고 있습니다.

세계 축산물 생산량 증가도 향후 인수공통전염병 치료제 시장의 성장을 가속할 것으로 예측됩니다. 축산은 식량, 섬유, 노동력, 기타 인간을 위한 제품을 생산하기 위해 가축을 조직적으로 사육, 사육, 관리하는 것을 말합니다. 축산업 확대의 배경에는 인구 증가와 식습관 변화에 따른 동물성 식품에 대한 수요 증가가 있습니다. 축산업은 질병 감시, 조사, 동물위생관리의 핵심으로 인수공통전염병 치료에 있으며, 매우 중요한 역할을 담당하고 있습니다. 이를 통해 병원체 조기 발견, 백신 및 치료제 개발, 동물과 인간 간 질병 전파를 억제하는 생물안전 대책 시행이 가능해져 통합적인 원헬스 접근법을 지원하고 있습니다. 예를 들어 2025년 7월 영국 정부 기관의 공식 통계에 따르면 2024년 영국의 축산물 총생산액은 201억 파운드(236억 9,000만 달러)로 2023년 대비 11억 파운드(13억 달러), 5.6% 증가했습니다. 이는 주로 계란, 소고기, 유제품 부문의 가격 상승과 생산량 증가에 따른 것입니다. 따라서 전 세계 축산물 생산 확대가 인수공통전염병 치료제 시장의 성장을 촉진하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

Treatment for zoonotic diseases encompasses medical interventions and therapies designed to diagnose, manage, and prevent illnesses caused by pathogens transmitted between animals and humans. This treatment regimen typically combines medication, vaccination, hygiene protocols, and control measures to minimize transmission and alleviate the impact of these infections on both animal and human communities.

The primary diseases addressed in zoonotic disease treatment include rabies, tuberculosis, malaria, leishmaniasis, Ebola virus disease, and others. Rabies, for instance, is a viral illness characterized by acute inflammation of the brain in humans and other mammals, commonly transmitted through the bite of an infected animal. Zoonotic disease treatment encompasses various drug classes such as anti-fungal, anti-bacterial, antibiotics, and others, targeting diverse agents such as bacteria, viruses, nematodes, rodents, ticks, and others. Administration routes comprise oral, topical, and others, with distribution occurring through channels such as hospital pharmacies, retail pharmacies, online pharmacies, and others.

Tariffs have impacted the zoonotic disease treatment market by increasing costs of imported drugs, vaccines, and diagnostic supplies, affecting treatment affordability and supply continuity. Regions such as asia-pacific and africa are most affected due to reliance on imported pharmaceuticals and high disease burden. Segments including rabies prophylaxis, tuberculosis treatment, and antiviral therapies have faced cost pressures, while tariffs have also encouraged local manufacturing, regional partnerships, and development of cost-effective treatment solutions. Overall, tariffs have driven supply chain localization and strengthened domestic production capabilities.

The zoonotic disease treatment market research report is one of a series of new reports from The Business Research Company that provides zoonotic disease treatment market statistics, including zoonotic disease treatment industry global market size, regional shares, competitors with a zoonotic disease treatment market share, detailed zoonotic disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the zoonotic disease treatment industry. This zoonotic disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The zoonotic disease treatment market size has grown strongly in recent years. It will grow from $42.51 billion in 2025 to $45.48 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to frequent zoonotic disease transmission events, limited disease surveillance in animal populations, high dependence on conventional antibiotics, lack of coordinated animal and human health strategies, increased human-animal interaction.

The zoonotic disease treatment market size is expected to see strong growth in the next few years. It will grow to $57.77 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to advancements in zoonotic disease diagnostics and therapeutics, rising adoption of one health approaches, increasing government funding for zoonotic disease control, growing vaccination coverage in animals, expansion of global disease surveillance programs. Major trends in the forecast period include rising incidence of zoonotic disease outbreaks, increasing focus on preventive treatment and prophylaxis, growing demand for broad-spectrum anti-infective therapies, expansion of integrated animal and human health programs, emphasis on early diagnosis and rapid treatment initiation.

The rising demand for animal proteins is expected to drive the growth of the zoonotic disease treatment market in the coming years. Animal proteins are derived from sources such as meat, dairy, eggs, and fish and provide all essential amino acids required for human health. The growing demand for animal proteins is attributed to factors including population growth, increasing income levels, urbanization, and greater awareness of the nutritional benefits of animal-based diets. Zoonotic disease treatment supports the management of diseases associated with animal protein consumption by helping to understand transmission pathways, develop effective therapies, and implement preventive strategies to reduce public health risks. For example, in March 2025, according to the Australian Bureau of Statistics (ABS), Australia's official national statistical agency, per capita consumption of meat and poultry products increased by 2.3% compared with 2023-24, reflecting a notable rise in animal-based protein intake by weight in the national diet. Therefore, the growing demand for animal proteins is contributing to the expansion of the zoonotic disease treatment market.

The increase in global livestock production is also expected to propel the growth of the zoonotic disease treatment market going forward. Livestock production refers to the organized breeding, raising, and management of domesticated animals to produce food, fiber, labor, and other products for human use. The expansion of livestock production is driven by rising demand for animal-based food products resulting from population growth and evolving dietary preferences. Livestock production plays a critical role in zoonotic disease treatment by serving as a key point for disease surveillance, research, and animal health management. This enables early detection of pathogens, development of vaccines and therapeutics, and implementation of biosecurity measures that reduce disease transmission between animals and humans while supporting integrated One Health approaches. For instance, in July 2025, according to official statistics from UK government agencies, the total value of livestock output in the UK reached £20.1 billion ($23.69 billion) in 2024, an increase of £1.1 billion ($1.30 billion), or 5.6%, compared with 2023, largely driven by higher prices and increased production in the eggs, beef, and milk sectors. Therefore, growing global livestock production is driving the growth of the zoonotic disease treatment market.

Major companies operating in the zoonotic disease treatment market are increasingly investing in advanced diagnostic and therapeutic innovations to improve disease detection and treatment outcomes. These efforts include the development of advanced diagnostic technologies, such as PCR-based testing kits, to enable faster and more accurate identification of zoonotic pathogens, as well as the implementation of targeted treatment protocols. For example, in October 2023, BioPerfectus, a China-based biotechnology company specializing in diagnostic solutions, launched thirteen new additions to its Zoonotic Infectious Diseases Total PCR Solution. This expansion is intended to strengthen diagnostic capabilities for zoonotic diseases, which account for more than 60% of known infectious diseases and 75% of emerging infections. The initiative aims to enhance health security preparedness and response, particularly as climate change contributes to the spread of infectious diseases into new regions, supporting faster diagnosis and more effective management of zoonotic infections.

Major companies operating in the zoonotic disease treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Sante Animale, Vir Biotechnology Inc., Virbac, Vetoquinol S.A., BioCryst Pharmaceuticals Inc, Heska Corporation

North America was the largest region in the zoonotic disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the zoonotic disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the zoonotic disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The zoonotic disease treatment market consists of revenues earned by entities by providing services such as vaccinations, antimicrobial therapy, supportive care, and vector control. The market value includes the value of related goods sold by the service provider or included within the service offering. The zoonotic disease treatment market also includes sales of diagnostic kits, antimicrobial medications (antiparasitic, immunomodulators), and vector control products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Zoonotic Disease Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses zoonotic disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for zoonotic disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The zoonotic disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Disease Type: Rabies; Tuberculosis; Leishmaniasis; Ebola Virus Disease; Other Disease Types
• 2) By Drug Class: Anti-Fungal; Anti-Bacterial; Antibiotics; Other Drug Classes
• 3) By Causative Agent: Bacteria; Virus; Nematode; Rodents; Ticks; Other Causative Agents
• 4) By Route Of Administration: Oral; Topical; Other Routes Of Administrations
• 5) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
• Subsegments:
• 1) By Rabies: Post Exposure Prophylaxis (PEP); Pre-Exposure Prophylaxis (PrEP)
• 2) By Tuberculosis: Latent Tuberculosis Treatment; Active Tuberculosis Treatment
• 3) By Leishmaniasis: Visceral Leishmaniasis; Cutaneous Leishmaniasis; Mucocutaneous Leishmaniasis
• 4) By Ebola Virus Disease: Pre-Exposure Vaccination; Post-Exposure Treatment
• 5) By Other Disease Types: Zika Virus; Lassa Fever; Yellow Fever; Chikungunya
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck And Co. Inc.; Bayer AG; Sanofi S.A.; AstraZeneca plc; Novartis International AG; F. Hoffmann-La Roche Ltd.; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Teva Pharmaceutical Industries Ltd.; Zoetis Inc.; Boehringer Ingelheim International GmbH; Elanco Animal Health Incorporated; IDEXX Laboretories Inc.; Hikma Pharmaceuticals PLC.; Ceva Sante Animale; Vir Biotechnology Inc.; Virbac; Vetoquinol S.A.; BioCryst Pharmaceuticals Inc; Heska Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Zoonotic Disease Treatment Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Zoonotic Disease Treatment Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Zoonotic Disease Treatment Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Zoonotic Disease Treatment Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.1.4 Sustainability, Climate Tech & Circular Economy
  • 4.1.5 Biotechnology, Genomics & Precision Medicine
• 4.2. Major Trends
  • 4.2.1 Rising Incidence Of Zoonotic Disease Outbreaks
  • 4.2.2 Increasing Focus On Preventive Treatment And Prophylaxis
  • 4.2.3 Growing Demand For Broad-Spectrum Anti-Infective Therapies
  • 4.2.4 Expansion Of Integrated Animal And Human Health Programs
  • 4.2.5 Emphasis On Early Diagnosis And Rapid Treatment Initiation

5. Zoonotic Disease Treatment Market Analysis Of End Use Industries

• 5.1 Hospitals And Healthcare Centers
• 5.2 Veterinary Hospitals And Clinics
• 5.3 Public Health Agencies
• 5.4 Research And Diagnostic Laboratories
• 5.5 Non-Governmental Health Organizations

6. Zoonotic Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Zoonotic Disease Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Zoonotic Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Zoonotic Disease Treatment Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Zoonotic Disease Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Zoonotic Disease Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Zoonotic Disease Treatment Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Zoonotic Disease Treatment Market Segmentation

• 9.1. Global Zoonotic Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Rabies, Tuberculosis, Leishmaniasis, Ebola Virus Disease, Other Disease Types
• 9.2. Global Zoonotic Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Anti-Fungal, Anti-Bacterial, Antibiotics, Other Drug Classes
• 9.3. Global Zoonotic Disease Treatment Market, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bacteria, Virus, Nematode, Rodents, Ticks, Other Causative Agents
• 9.4. Global Zoonotic Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Topical, Other Routes Of Administrations
• 9.5. Global Zoonotic Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
• 9.6. Global Zoonotic Disease Treatment Market, Sub-Segmentation Of Rabies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Post Exposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
• 9.7. Global Zoonotic Disease Treatment Market, Sub-Segmentation Of Tuberculosis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Latent Tuberculosis Treatment, Active Tuberculosis Treatment
• 9.8. Global Zoonotic Disease Treatment Market, Sub-Segmentation Of Leishmaniasis, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Visceral Leishmaniasis, Cutaneous Leishmaniasis, Mucocutaneous Leishmaniasis
• 9.9. Global Zoonotic Disease Treatment Market, Sub-Segmentation Of Ebola Virus Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pre-Exposure Vaccination, Post-Exposure Treatment
• 9.10. Global Zoonotic Disease Treatment Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Zika Virus, Lassa Fever, Yellow Fever, Chikungunya

10. Zoonotic Disease Treatment Market Regional And Country Analysis

• 10.1. Global Zoonotic Disease Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Zoonotic Disease Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Zoonotic Disease Treatment Market

• 11.1. Asia-Pacific Zoonotic Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Zoonotic Disease Treatment Market

• 12.1. China Zoonotic Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Zoonotic Disease Treatment Market

• 13.1. India Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Zoonotic Disease Treatment Market

• 14.1. Japan Zoonotic Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Zoonotic Disease Treatment Market

• 15.1. Australia Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Zoonotic Disease Treatment Market

• 16.1. Indonesia Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Zoonotic Disease Treatment Market

• 17.1. South Korea Zoonotic Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Zoonotic Disease Treatment Market

• 18.1. Taiwan Zoonotic Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Zoonotic Disease Treatment Market

• 19.1. South East Asia Zoonotic Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Zoonotic Disease Treatment Market

• 20.1. Western Europe Zoonotic Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Zoonotic Disease Treatment Market

• 21.1. UK Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Zoonotic Disease Treatment Market

• 22.1. Germany Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Zoonotic Disease Treatment Market

• 23.1. France Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Zoonotic Disease Treatment Market

• 24.1. Italy Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Zoonotic Disease Treatment Market

• 25.1. Spain Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Zoonotic Disease Treatment Market

• 26.1. Eastern Europe Zoonotic Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Zoonotic Disease Treatment Market

• 27.1. Russia Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Zoonotic Disease Treatment Market

• 28.1. North America Zoonotic Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Zoonotic Disease Treatment Market

• 29.1. USA Zoonotic Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Zoonotic Disease Treatment Market

• 30.1. Canada Zoonotic Disease Treatment Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Zoonotic Disease Treatment Market

• 31.1. South America Zoonotic Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Zoonotic Disease Treatment Market

• 32.1. Brazil Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Zoonotic Disease Treatment Market

• 33.1. Middle East Zoonotic Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Zoonotic Disease Treatment Market

• 34.1. Africa Zoonotic Disease Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Zoonotic Disease Treatment Market, Segmentation By Disease Type, Segmentation By Drug Class, Segmentation By Causative Agent, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Zoonotic Disease Treatment Market Regulatory and Investment Landscape

36. Zoonotic Disease Treatment Market Competitive Landscape And Company Profiles

• 36.1. Zoonotic Disease Treatment Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Zoonotic Disease Treatment Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Zoonotic Disease Treatment Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Zoonotic Disease Treatment Market Other Major And Innovative Companies

• AstraZeneca plc, Novartis International AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, IDEXX Laboretories Inc., Hikma Pharmaceuticals PLC., Ceva Sante Animale, Vir Biotechnology Inc., Virbac

38. Global Zoonotic Disease Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Zoonotic Disease Treatment Market

40. Zoonotic Disease Treatment Market High Potential Countries, Segments and Strategies

• 40.1 Zoonotic Disease Treatment Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Zoonotic Disease Treatment Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Zoonotic Disease Treatment Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer